New study aims to help pregnant moms quit smoking and vaping at once

NCT ID NCT07124702

Recruiting now Disease control Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study enrolls 45 pregnant women who use both cigarettes and e-cigarettes. Participants are split into three groups: one that tries to quit both at the same time, one that quits cigarettes first then e-cigarettes, and a control group. All receive counseling, feedback on nicotine levels, and financial rewards for staying nicotine-free. The goal is to see which approach works best for achieving and maintaining nicotine abstinence during pregnancy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (counseling, biomarker feedback, and financial incentives)
What this could lead to: If successful, this could provide an effective program to help pregnant women quit both smoking and vaping, improving health for mother and baby.
What could go wrong: This is a very small early-stage trial (45 participants) and may not show clear results. Quitting nicotine is difficult, and relapse is common.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIRTH-WEIGHT-FOR-GESTATIONAL-AGE Z SCORE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gestational Weight Gain Tobacco Use Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIRTH-WEIGHT-FOR-GESTATIONAL-AGE Z SCORE DUAL USE OF CIGARETTES AND E-CIGARETTES GESTATIONAL WEIGHT GAIN

Contacts and locations

Locations

State University of New York at Buffalo
RECRUITING

Buffalo, New York, 14214, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.